UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~WASHINGTON~~Washington, DCD.C. 20549

FORM 8-K

CURRENT REPORT

~~PURSUANT~~Pursuant TOto ~~SECTION~~Section 13 ORor 15(d) of the Securities Exchange Act of 1934

OFSeptember ~~THE~~15, ~~SECURITIES EXCHANGE ACT OF 1934~~2011

Date of Report (Date of earliest event reported)~~: December 17th, 2010~~

NHS ~~HEALTH~~Health ~~SOLUTIONS~~Solutions, ~~INC~~Inc.

(Exact name of ~~Registrant~~registrant as specified in its charter)

NEVADA	0-25127	91-1715373
(State or other jurisdiction	(Commission File Number)	(IRS EIN)
of incorporation)

Nevada

~~13520~~(State ~~Oriental~~or StOther Jurisdiction of Incorporation)

~~Rockville, Md 20853~~000-25127

(~~Address~~Commission ofFile ~~principal executive offices~~Number)

~~Registrant's telephone number, including area code: 202 536~~91-~~5191~~1715373

~~3720~~(IRS ~~West~~Employer ~~Oquendo~~Identification ~~Rd, Suite #101,~~No.)

~~Las~~39 ~~Vegas,~~Acorn ~~NV 89118~~ Lane

~~(Former~~Hilton ~~name~~Head ~~or former address~~Island, ifSC ~~changed since last report)~~29928

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14[a-12)
o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

(Address of Principal Executive Offices and Zip Code)

~~ITEM~~(843) ~~1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.~~683-6477

~~On December 17th 2010~~ (~~the~~Registrant’s ~~“Closing~~Telephone ~~Date”)~~Number, ~~Jeff~~Including ~~Digenova~~Area ~~acquired the majority of the issued and outstanding common stock of NHS HEALTH SOLUTIONS, INC., a Nevada corporation (the “Company”~~Code), in accordance with a stock purchase agreement (the “Stock Purchase Agreement”) by and between NPNC Management LLC and Mr. Digenova. On the Closing Date, pursuant to the terms of the Stock Purchase Agreement, Mr. Digenova purchased 1,000,000 shares of common stock for $140,000.00.

~~ITEM~~Check ~~5.01.~~the ~~CHANGES~~appropriate INbox ~~CONTROL~~below OFif ~~REGISTRANT.~~the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

On the Closing Date, pursuant to the terms of the Stock Purchase Agreement, Jeff Digenova purchased a total of 1,000,000 shares of the Company’s common stock. As a result of a Share Purchase Agreement the Company experienced a Change in Control under which 73.77% of the shares of the company are now held by Mr. Digenova, the new majority shareholder.[__]

~~ITEM~~Written ~~5.02.~~communications ~~DEPARTURE~~pursuant OFto ~~DIRECTORS~~Rule OR425 ~~PRINCIPAL~~under ~~OFFICERS;~~the ~~ELECTION~~Securities OFAct ~~DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS.~~

In(17 ~~accordance~~CFR ~~with the change in control David Woo resigned as the Company's President, CEO, and any other positions held by him on December 17th, 2010~~230. ~~The resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.~~425)

~~On the same date Jeff Digenova was appointed as Director of the Company.~~[__]

AsSoliciting ~~of the date of this filing, there has not been any~~ material ~~plan,~~pursuant ~~contract or arrangement (whether or not written)~~ to ~~which Jeff~~Rule ~~Digenova~~14a-12 isunder athe ~~party~~Exchange inAct ~~connection with this appointment as a director and an officer of this Company.~~

~~ITEM~~(17 ~~9.01.~~CFR ~~EXHIBITS~~240.14a-12)

(d)	Exhibits.
	Exhibit #	Description
	99.1	Written Consent of Resolutions of Resignatation and Appointment.
	99.2	Board of Director’s Resolution appointing David E. Price as Secretary of the Corporation.
	10.1	Securities Purchase Agreement

[__]

~~SIGNATURES~~Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

~~Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.~~[__]

	NHS Health Solutions, Inc.
Date: January 4, 2011	By:	/s/ Jeffrey Digenova
		Jeffrey Digenova Chief Executive Officer

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

Section 1 – Registrant’s Business and Operations

Item 1.01 Entry into a Material Definitive Agreement.

On September 14, 2011, NHS Health Solutions, Inc. (“NHS” or the “Company”) entered into a binding Letter of Intent with Mineseeker Operations Overseas Ltd., a British Virgin Islands corporation (“Mineseeker”), wherein NHS agreed to enter into a tax-free share exchange whereby Mineseeker would become a wholly-owned subsidiary of NHS. The parties agreed to begin diligence process immediately with a view toward entering into a formal agreement within 30 days from the date of the Letter of Intent to facilitate the share exchange, unless such date is extended pursuant to a mutual agreement of the parties.

Mineseeker is an aerial survey and mapping company, using innovative technology producing a fusion of multi-spectral images of both surface and sub-surface targets, designed specifically to identify and locate landmines and unexploded remnants of war. The technology, which has been developed and extensively trialled can survey up to 5 square kilometres per day, significantly reducing the time and cost of releasing land back to economically productive use when compared with traditional mine clearance methods.

Mineseeker, through its Aid Free Zones, then works with governments and land owners to develop economically sustainable solutions through its program of compassionate capitalism to deliver wealth in partnership with the local populations thereby removing their reliance on aid handouts and driving exciting investor returns.

Section 9 – Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits.

Exhibit 10.1 – Letter of Intent dated September 14, 2011

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NHS HEALTH SOLUTIONS, INC.

By:

/s/: Jeffrey DiGenova

Jeffrey DiGenova, Chief Executive Officer

DATED: September 15, 2011.

Filing Compare · NHS Health Solutions, Inc